Quantcast

Latest Peptides Stories

cd9f292bc56f0abdbd2ad8e308dd53151
2010-10-30 12:45:46

Researchers led by Vanderbilt's Roger Cone, Ph.D., have discovered a new member of a gene family that has powerful influences on pigmentation and the regulation of body weight.The gene is the third member of the agouti family. Two agouti genes have been identified previously in humans. One helps determine skin and hair color, and the other may play an important role in obesity and diabetes. The new gene, called agrp2, has been found exclusively in bony fish, including zebrafish, trout and...

2010-10-26 09:17:00

BASKING RIDGE, N.J., Oct. 26 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the Oppenheimer 21st Annual Healthcare Conference. Dr. Mazzo's presentation will be given at the Waldorf-Astoria Hotel in New York City on Tuesday, November 2, 2010 at 10:45 a.m. EDT in the Louis XVI Room. The presentation will include an overview...

2010-09-30 09:12:28

(Ivanhoe Newswire) -- Researchers have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage using aptamer-based proteomics array technology. This novel technology would enable better clinical diagnosis for two of the most aggressive and deadly forms of cancer -- pancreatic and mesothelioma.  Moreover, it would provide insight into new therapeutic targets. "Currently these cancers are detected at an advanced stage, where the possibility of cure is...

2010-09-28 20:51:00

Using a novel aptamer-based proteomics array technology, researchers and collaborators have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage for two of the most aggressive and deadly forms of cancer "” pancreatic and mesothelioma. This technology would enable better clinical diagnosis at an earlier stage and may provide insight into new therapeutic targets, said Rachel Ostroff, Ph.D., clinical research director of Somalogic Inc. "Currently...

2010-09-16 09:17:00

BASKING RIDGE, N.J., Sept. 16 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the UBS Global Life Sciences Conference. Dr. Mazzo's presentation will be given at the Grand Hyatt Hotel in New York City on Wednesday, September 22, 2010 at 8:00 a.m. EDT in Ballroom V. The presentation will include an overview of the Company's...

2010-09-09 09:17:00

BASKING RIDGE, N.J., Sept. 9 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the Stifel Nicolaus Healthcare Conference at the Four Seasons Hotel located at 200 Boylston Street in Boston, Massachusetts. Dr. Mazzo's presentation will be given at 2:40 pm EDT in the Winthrop Room and will include an overview of the Company's...

2010-08-05 15:29:38

Phase 3 trials of icatibant show rapid symptom relief with no serious side effects Clinical trials from two international research teams have shown that icatibant, a new drug that blocks the action of an inflammatory protein known as bradykinin, is safe and effective in treating acute attacks of hereditary angioedema, a potentially life-threatening condition. In their report in the August 5 New England Journal of Medicine, the authors note that "“ while the results of one trial did not...

2010-08-02 19:04:36

New research in the FASEB Journal shows that a peptide derived from bee venom can deliver liposomes bearing drugs or diagnostic dyes to specific cells or tissues The next time you are stung by a bee, here's some consolation: a toxic protein in bee venom, when altered, significantly improves the effectiveness liposome-encapsulated drugs or dyes, such as those already used to treat or diagnose cancer. This research, described in the August 2010 print issue of the FASEB Journal...

2010-07-27 09:17:00

BASKING RIDGE, N.J., July 27 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, Ph.D., President and CEO, will be presenting at Wedbush Securities Life Sciences Best Ideas MAC: Management Access Conference at the Parker Meridien Hotel in New York City on August 3, 2010. Dr. Mazzo's presentation will be given at 8:00 a.m. EDT in the Lorica Room and will include an...

2010-07-26 15:05:00

BASKING RIDGE, N.J., July 26 /PRNewswire/ -- Regado Biosciences, Inc., a privately held biopharmaceutical company pioneering the development of a novel two-component antithrombotic drug technology consisting of therapeutic aptamers with their matched active control agents, announced publication of results from a Phase 2a study for its lead compound, the REG1 system. The study is known as REVERSAL-PCI. The company's REG1 technology, a selective coagulation factor IXa inhibiting aptamer...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related